Related Experiment Videos
[Myocardial revascularization in patients with severely depressed left ventricular function]
F Nicolini1, A Carcagnì, E Citterio
1Unità Operativa di Cardiochirurgia, Istituto Clinico Humanitas, Rozzano, MI.
Cardiologia (Rome, Italy)
|August 12, 1999
Summary
Coronary artery bypass grafting (CABG) offers excellent outcomes for patients with severe left ventricular dysfunction and coronary artery disease. This high-risk surgery improves heart function and patient survival rates.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Cardiology
Context:
- Patients with left ventricular dysfunction face increased risks during cardiac surgery.
- Coronary artery bypass grafting (CABG) in patients with ejection fraction < or = 0.30 presents significant surgical challenges.
- Advances in anesthetic and surgical techniques have improved outcomes for these high-risk patients.
Purpose:
- To evaluate the safety and efficacy of CABG in patients with end-stage coronary artery disease and severely reduced left ventricular ejection fraction (LVEF).
- To assess perioperative mortality, morbidity, and long-term outcomes in this specific patient cohort.
Summary:
- Fifty-one patients with LVEF between 16-30% underwent CABG.
- No operative or in-hospital deaths occurred; postoperative complications included low cardiac output syndrome (15.7%) and major neurological events (3.9%).
- Postoperative LVEF improved significantly (25.5% to 31.3%), with enhanced NYHA functional class and an excellent long-term prognosis.
Impact:
- CABG is a viable and effective treatment option for carefully selected high-risk patients with ischemic heart disease and severely impaired left ventricular function.
- The procedure significantly improves functional capacity, clinical outcomes, and life expectancy in this patient population.
- This study highlights the potential for successful surgical intervention in patients previously considered poor surgical candidates.